49.84
+0.48
+(0.97%)
At close: January 30 at 4:00:01 PM EST
49.01
-0.83
(-1.67%)
Pre-Market: 7:06:33 AM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
180,691.00
26,497.00
35,553.00
64,982.00
Total Liabilities Net Minority Interest
23,184.00
16,149.00
17,760.00
19,435.00
Total Equity Gross Minority Interest
157,507.00
10,348.00
17,793.00
45,547.00
Total Capitalization
157,507.00
10,348.00
17,793.00
45,547.00
Common Stock Equity
157,507.00
10,348.00
17,793.00
45,547.00
Capital Lease Obligations
403.00
155.00
457.00
139.00
Net Tangible Assets
148,758.00
-345.00
5,156.00
30,966.00
Working Capital
159,853.00
8,334.00
14,415.00
41,625.00
Invested Capital
157,507.00
10,348.00
17,793.00
45,547.00
Tangible Book Value
148,758.00
-345.00
5,156.00
30,966.00
Total Debt
403.00
155.00
457.00
139.00
Share Issued
31,678.16
8,159.38
5,324.29
5,307.71
Ordinary Shares Number
31,678.16
8,159.38
5,324.29
5,307.71
12/31/2020 - 11/13/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RYTM Rhythm Pharmaceuticals, Inc.
59.22
+3.55%
VRDN Viridian Therapeutics, Inc.
20.08
+3.35%
CRNX Crinetics Pharmaceuticals, Inc.
40.26
+2.23%
APGE Apogee Therapeutics, Inc.
42.50
+5.41%
RNA Avidity Biosciences, Inc.
32.63
+2.22%
CGEM Cullinan Therapeutics, Inc.
10.98
-2.40%
PRAX Praxis Precision Medicines, Inc.
76.20
+2.95%
VERA Vera Therapeutics, Inc.
37.48
-1.19%
MRUS Merus N.V.
41.57
-0.19%
KRYS Krystal Biotech, Inc.
156.07
-0.15%